Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in australia (1991 to 1996).

No abstract is available for this paper.

• Publication year

  2001

• Venue

  PharmacoEconomics (Auckland)

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Economics

• Identifiers
  PMID 11735677
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacoeconomic guidelines: where do we go from here?

  2001cited by this paper
• One thousand health-related quality-of-life estimates.

  2000cited by this paper
• Problems with the interpretation of pharmacoeconomic analyses: a review of submissions to the Australian Pharmaceutical Benefits Scheme.

  2000cited by this paper
• Theory and methods of economic evaluation of health care.

  1996cited by this paper
• Using willingness to pay to assess the benefits of assisted reproductive techniques.

  1996cited by this paper
• Cost-per-QALY league tables: their role in pharmacoeconomic analysis.

  1994cited by this paper
• Cost utility analysis: what should be measured?

  1994cited by this paper
• Willingness to pay for diagnostic services. A new approach to modelling patient benefits in health care.

  1994cited by this paper
• Willingness to pay for antihypertensive therapy--further results.

  1993cited by this paper
• QALY league tables: handle with care.

  1993cited by this paper
• Cost-effectiveness league tables: more harm than good?

  1993cited by this paper
• Setting health care priorities in Oregon. Cost-effectiveness meets the rule of rescue.

  1991cited by this paper
• Economics of coronary artery bypass grafting.

  1985cited by this paper

• Evaluating Cost‐Effectiveness of 85 Endoscopic Surveillance Strategies of Nondysplastic Barrett's Esophagus

  2026cites this paper
• COST-EFFECTIVENESS OF COGNITIVE BEHAVIOURAL THERAPY VERSUS HEALTH EDUCATION FOR SLEEP DISTURBANCE AND FATIGUE FOLLOWING STROKE AND TRAUMATIC BRAIN INJURY

  2025cites this paper
• Prevention pays: Investing in Australia's health and economic future.

  2025cites this paper
• Cost-effectiveness analysis of active day patient treatment, an interdisciplinary pain self-management program

  2025cites this paper
• Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI).

  2025cites this paper
• Cost‐Effectiveness of the Tailored Activity Programme for Person With Dementia‐Caregiver Dyads: A Markov Model

  2025cites this paper
• Comparison of Cost-Effectiveness Between Digital Health Interventions and Pharmacotherapy for Depression: Systematic Review

  2025cites this paper
• Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study and cost-effectiveness analysis.

  2024cites this paper
• Cost-utility analysis of adjunct repetitive transcranial magnetic stimulation for treatment resistant bipolar depression.

  2024cites this paper
• Population impact and cost-effectiveness of artificial intelligence-based diabetic retinopathy screening in people living with diabetes in Australia: a cost effectiveness analysis

  2024cites this paper
• Exploring the uptake of economic evaluation in Spanish reports positioning medicines for public reimbursement

  2024cites this paper
• Cost saving and predictive factors of response to rituximab in rheumatoid arthritis, including the IL-6 promoter gene polymorphism

  2024cites this paper
• Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease

  2024cites this paper
• Cost-effectiveness of reducing children’s sedentary time and increasing physical activity at school: the Transform-Us! intervention

  2024cites this paper
• Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges

  2024cites this paper
• The implementation and mechanisms of advance notification for cancer screening: A scoping review

  2024cites this paper
• A cost-effectiveness evaluation of a dietitian-delivered telephone coaching program during pregnancy for preventing gestational diabetes mellitus

  2024cites this paper
• Finding value in novel antibiotics: How can infectious diseases adopt incremental cost-effectiveness to improve new antibiotic utilization?

  2024cites this paper
• Cost-effectiveness of treating serendipitously diagnosed anal pre-cancerous lesions among gay, bisexual and other men who have sex with men living with HIV

  2023cites this paper
• A systematic review of whole disease models for informing healthcare resource allocation decisions

  2023cites this paper
• Cost-effectiveness of Prednisolone to Treat Bell Palsy in Children

  2023cites this paper
• Should additional value elements be included in cost-effectiveness analysis in pharmacoeconomic evaluation: a novel commentary

  2023cites this paper
• The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer

  2023cites this paper
• Cost-effectiveness of screening and treating anal pre-cancerous lesions among gay, bisexual and other men who have sex with men living with HIV

  2023cites this paper
• Cost-effectiveness analysis of sedentary behaviour interventions in offices to reduce sitting time in Australian desk-based workers: A modelling study

  2023cites this paper
• A systematic review of economic evaluations of interventions targeting childhood overweight and obesity

  2023cites this paper
• Risk-based decision-making related to preprocedural coronavirus disease 2019 testing in the setting of GI endoscopy: management of risks, evidence, and behavioral health economics

  2022cites this paper
• Economic evaluation of the Target-D platform to match depression management to severity prognosis in primary care: A within-trial cost-utility analysis

  2022cites this paper
• The Cost-Effectiveness Evaluation of the Intraoperative Additional Photodynamic Therapy for the Treatment of Newly Diagnosed Glioblastoma

  2022cites this paper
• Reflexive Evidence and Systems interventions to Prevention Obesity and Non-communicable Disease (RESPOND): protocol and baseline outcomes for a stepped-wedge cluster-randomised prevention trial

  2022cites this paper
• Cost‐effectiveness of scaling up a whole‐of‐community intervention: The Romp & Chomp early childhood obesity prevention intervention

  2022cites this paper
• Modelling futility in the setting of fertility treatment.

  2022cites this paper
• What are the impacts of increasing cost-effectiveness Threshold? a protocol on an empirical study based on economic evaluations conducted in Thailand

  2022cites this paper
• Economics of sedentary behaviour: A systematic review of cost of illness, cost-effectiveness, and return on investment studies.

  2022cites this paper
• Cost–Benefit and Cost–Utility Analyses to Demonstrate the Potential Value-for-Money of Supermarket Shelf Tags Promoting Healthier Packaged Products in Australia

  2022cites this paper
• A cost-effectiveness model for a decision to adopt temporary single-patient rooms to reduce risks of healthcare-associated infection in the Australian public healthcare system.

  2022cites this paper
• On the impacts of the COVID-19 pandemic on mortality: Lost years or lost days?

  2022cites this paper
• Economic evaluation of digitally enabled aged and neurological rehabilitation care in the Activity and MObility UsiNg Technology (AMOUNT) trial

  2022cites this paper
• Cost-effectiveness of LiveLighter® - a mass media public education campaign for obesity prevention

  2022cites this paper
• Economic evaluation of an incentive-based program to increase physical activity and reduce sedentary behaviour in middle-aged adults

  2022cites this paper
• Exploring the economics of public health intervention scale-up: a case study of the Supporting Healthy Image, Nutrition and Exercise (SHINE) cluster randomised controlled trial

  2022cites this paper
• Factors associated with Pharmaceutical Benefits Advisory Committee decisions for listing medicines for diabetes and its associated complications.

  2022cites this paper
• Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries

  2021cites this paper
• The economic theory of cost-effectiveness thresholds in health: Domestic and international implications.

  2021cites this paper
• Biologics for severe, chronic plaque psoriasis: An Australian cost-utility analysis

  2021cites this paper
• A cost–benefit analysis framework for preventive health interventions to aid decision-making in Australian governments

  2021cites this paper
• How Much Is a Human Life Worth? A Systematic Review.

  2021cites this paper
• A systematic review of economic evaluations of web‐based or telephone‐delivered interventions for preventing overweight and obesity and/or improving obesity‐related behaviors

  2021cites this paper
• Modelling the Cost-Effectiveness of Latent Tuberculosis Screening and Treatment Strategies in Recent Migrants to a Low Incidence Setting.

  2021cites this paper
• Systematic Review to Update ‘Value of a Statistical Life’ Estimates for Australia

  2021cites this paper
• Economic evaluation of an Australian nurse home visiting programme: a randomised trial at 3 years

  2021cites this paper
• Tobacco dependence treatment in Australia - an untapped opportunity for reducing the smoking burden.

  2020cites this paper
• Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in healthy subjects aged 3 to 17 years old: A phase III, open label, single-arm study.

  2020cites this paper
• Priority-setting for obesity prevention—The Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) study

  2020cites this paper
• Understanding the global measurement of willingness to pay in health

  2020cites this paper
• Is the whole larger than the sum of its parts? Impact of missing data imputation in economic evaluation conducted alongside randomized controlled trials

  2020cites this paper
• Increasing the Price of Alcohol as an Obesity Prevention Measure: The Potential Cost-Effectiveness of Introducing a Uniform Volumetric Tax and a Minimum Floor Price on Alcohol in Australia

  2020cites this paper
• Protocol for economic evaluation alongside the SHINE (Supporting Healthy Image, Nutrition and Exercise) cluster randomised controlled trial

  2020cites this paper
• The potential for long‐term cost‐effectiveness of obesity prevention interventions in the early years of life

  2019cites this paper
• Cost-Effectiveness of S witching Patients With Heart Failure and Reduced Ejection Fraction to Sacubitril/Valsartan: The Australian Perspective

  2019cites this paper
• Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer Patients

  2019cites this paper
• Economic evaluation of deep-brain stimulation for Tourette’s syndrome: an initial exploration

  2019cites this paper
• Cost-effectiveness of epileptic surgery compared with medical treatment in children with drug-resistant epilepsy.

  2019cites this paper
• Evaluation of a telehealth psychological support intervention for people with primary brain tumour and their family members: Study protocol for a randomised controlled trial.

  2019cites this paper
• The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia

  2019cites this paper
• A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy

  2019cites this paper
• The potential cost-effectiveness of mandatory restrictions on price promotions for sugar-sweetened beverages in Australia

  2019cites this paper
• Cost-Effectiveness of Switching Patients With Heart Failure and Reduced Ejection Fraction to Sacubitril/Valsartan: The Australian Perspective.

  2019cites this paper
• Cost-effectiveness of community-based childhood obesity prevention interventions in Australia

  2019cites this paper
• One-year cost-effectiveness of supervised center-based exercise training in addition to a post-discharge disease management program for patients recently hospitalized with acute heart failure: The EJECTION-HF study.

  2019cites this paper
• Approaches to Aggregation and Decision Making (cid:886) A Health Economics Approach: An ISPOR Special Task Force Report

  2019cites this paper
• Expanding the breadth of Medicare: learning from Australia

  2018cites this paper
• Community views on factors affecting medicines resource allocation: cross-sectional survey of 3080 adults in Australia.

  2018cites this paper
• The development of funding recommendations for health technologies at the state level: A South Australian case study

  2018cites this paper
• Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3].

  2018cites this paper
• Exploring the use of economic evidence to inform investment in disease prevention – a qualitative study

  2018cites this paper
• Cost effectiveness and cost-utility analysis of a group-based diet intervention for treating major depression – the HELFIMED trial

  2018cites this paper
• Heatwave and elderly mortality: An evaluation of death burden and health costs considering short-term mortality displacement.

  2018cites this paper
• Economic evaluations of internet- and mobile-based interventions for the treatment and prevention of depression: A systematic review.

  2018cites this paper
• Implications of global pricing policies on access to innovative drugs: the case of trastuzumab in seven Latin American countries Short title: Global pricing and access: trastuzumab in Latin America

  2018cites this paper
• Cost-Effectiveness of Renal Denervation Therapy for Treatment-Resistant Hypertension: A Best Case Scenario

  2018cites this paper
• Economic evaluation of the NET intervention versus guideline dissemination for management of mild head injury in hospital emergency departments

  2018cites this paper
• Evaluation of willingness to pay per quality-adjusted life year for a cure

  2018cites this paper
• Are the benefits of new health services greater than their opportunity costs?

  2018cites this paper
• Family history–based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios

  2018cites this paper
• Comparing the ICERs in Medicine Reimbursement Submissions to NICE and PBAC-Does the Presence of an Explicit Threshold Affect the ICER Proposed?

  2018cites this paper
• Economic methods of medical technology assessment in hematology

  2018cites this paper
• Approaches to Aggregation and Decision Making—A Health Economics Approach: An ISPOR Special Task Force Report [5]

  2018cites this paper
• Prices For Common Cardiovascular Drugs In The US Are Not Consistently Aligned With Value.

  2018cites this paper
• Assessing cost-effectiveness of obesity prevention policies in Australia

  2018cites this paper
• Economic evaluation of a nurse-led home and clinic-based secondary prevention programme to prevent progressive cardiac dysfunction in high-risk individuals: The Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) randomized controlled study

  2018cites this paper
• The Potential Cost-Effectiveness and Equity Impacts of Restricting Television Advertising of Unhealthy Food and Beverages to Australian Children

  2018cites this paper
• Economic evaluation of interventions designed to reduce Clostridium difficile infection

  2018cites this paper
• Cost-effectiveness evaluation of the 45-49 year old health check versus usual care in Australian general practice: A modelling study

  2018cites this paper
• Explicit Cost-Effectiveness Thresholds in Health Care: A Kaleidoscope

  2018cites this paper
• Towards a Transparent, Credible, Evidence-Based Decision-Making Process of New Drug Listing on the Hong Kong Hospital Authority Drug Formulary: Challenges and Suggestions

  2018cites this paper
• How to design the cost‐effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework

  2018cites this paper
• Life satisfaction, QALYs, and the monetary value of health.

  2018cites this paper
• Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer.

  2018cites this paper
• Obesity‐related health impacts of active transport policies in Australia – a policy review and health impact modelling study

  2017cites this paper